EFFICACY AND SAFETY OF CMV-SPECIFIC T CELL LINE (CMV-TCL) FOR CMV REACTIVATIONS IN HIGH RISK ADULT PATIENTS (PTS) AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)

被引:0
|
作者
Bramanti, S. [1 ]
Comoli, P. [2 ]
Vai, A. [1 ]
Crocchiolo, R. [1 ]
Sarina, B. [1 ]
Basso, S. [2 ]
Mineri, R. [1 ]
Santoro, A. [1 ]
Castagna, L. [1 ]
机构
[1] Humanitas Canc Ctr, Rozzano, Italy
[2] Policlin San Matteo, I-27100 Pavia, Italy
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
PH-P494
引用
收藏
页码:S336 / S336
页数:1
相关论文
共 50 条
  • [1] CMV-specific T Cell Counts Early after Allogeneic Hematopoietic Stem Cell Transplantation Stratify the Risk of Subsequent CMV Reactivations: Results of a Prospective Observational Study
    Noviello, Maddalena
    Tassi, Elena
    De Simone, Pantaleo
    Serio, Francesca
    Lupo-Stanghellini, Maria Teresa
    Oliveira, Giacomo
    Racca, Sara
    Dvir, Roee
    Lazzari, Lorenzo
    Clerici, Daniela
    Giglio, Fabio
    Lorentino, Francesca
    Corti, Consuelo
    Bernardi, Massimo
    Brix, Liselotte
    Ciceri, Fabio
    Peccatori, Jacopo
    Greco, Raffaella
    Bonini, Chiara
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 530 - 531
  • [2] SIGNATURE PROFILES OF CMV-SPECIFIC T-CELLS IN PATIENTS WITH CMV REACTIVATION AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Kalina, Tomas
    Krol, Ladislav
    Stuchly, Jan
    Keslova, Petra
    Hubacek, Petr
    Sedlacek, Petr
    Stary, Jan
    Ondrej, Hrusak
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2010, 78B (06) : 409 - 409
  • [3] Polyfunctional CMV-specific T-cell response as a hallmark of protection from CMV reactivations in children after haematopoietic stem cell transplantation
    Krol, L.
    Kotus, D.
    Stuchly, J.
    Hubacek, P.
    Sedlacek, P.
    Kalina, T.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S51 - S51
  • [4] SIGNATURE PROFILES OF CMV-SPECIFIC T-CELLS IN PEDIATRIC PATIENTS WITH CMV REACTIVATION AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Krol, L.
    Stuchly, J.
    Hubacek, P.
    Sedlacek, P.
    Kalina, T.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S267 - S267
  • [5] CMV Reactivations and Their Impact On Outcomes in Patients After Hematopoietic Cell Transplantation
    Alam, Naheed
    Lambie, Anna
    Yunes, Yvette Neme
    Alfraih, Feras
    Atenafu, Eshetu G.
    Kim, Dennis Dong Hwan
    Gupta, Vikas
    Kuruvilla, John
    Lipton, Jeff H.
    Messner, Hans A.
    BLOOD, 2012, 120 (21)
  • [6] Adoptive transfer of CMV-specific TCR-T cells for the treatment of CMV infection after haploidentical hematopoietic stem cell transplantation
    Ma, Chao
    Chen, Peng
    Du, Jishan
    Wang, Lu
    Lu, Ning
    Sun, Jiaojun
    Xu, Qilong
    Wang, Yu
    Dou, Liping
    Liu, Dai-Hong
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (01)
  • [7] Adoptive Transfer of CMV-Specific TCR-T Cells for the Treatment of CMV Infection after Haploidentical Hematopoietic Stem Cell Transplantation
    Chao, Ma
    Liu Daihong
    Dou, Liping
    BLOOD, 2023, 142
  • [8] A Novel CMV-Specific TCR-T Cell Therapy Is Effective and Safe for Refractory CMV Infection after Allogeneic Hematopoietic Stem Cell Transplantation
    Cao, Xingyu
    Liu, Guangna
    Zhang, Jianping
    Zhao, Yanli
    Chen, Hua
    Zheng, Hongli
    Rui, Wei
    Jia, Lemei
    Zhao, Xueqiang
    Lin, Xin
    Lu, Peihua
    BLOOD, 2021, 138 : 3848 - +
  • [9] CMV-specific T-Cells for Treatment of CMV Infection after Hematopoietic Stem Cell Transplantation in a Pediatric Case: First Application in Turkey
    Celilova, Sevil
    Toret, Ersin
    Adakli, Basak Aksoy
    Ovali, Ercument
    Bozkurt, Ceyhun
    TURKISH JOURNAL OF HEMATOLOGY, 2020, 37 (01) : 65 - 67
  • [10] CMV-specific immune reconstitution in pediatric patients undergoing hematopoietic stem cell transplantation
    Lehrnbecher, T
    Preiser, W
    Köhl, U
    Bauer, G
    Fleckenstein, C
    Doerr, HW
    Klingebiel, T
    Buxbaum, S
    BONE MARROW TRANSPLANTATION, 2003, 31 : S231 - S232